Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021-Reference-Cited by-同舟云学术

Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021

Published:2021-07 Issue:1 Volume:80 Page:4-6
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fankhauser Christian Daniel^ORCID,Oldenburg Jan,Albers Peter,Algaba Ferran,Bokemeyer Carsten,Boormans Joost L.,Fischer Stefanie,Fizazi Karim,Gremmels Hendrik,Mayor de Castro Javier,Janisch Florian,Muilwijk Tim,Leão Ricardo,Nicol David,Nicolai Nicola,Tandstad Torgrim,Pilar Laguna M.

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer;Khorana;N Engl J Med,2019

2. Apixaban to prevent venous thromboembolism in patients with cancer;Carrier;N Engl J Med,2019

3. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer;Agnelli;N Engl J Med,2012

4. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study;Agnelli;Lancet Oncol,2009

5. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline update;Key;J Clin Oncol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023);Clinical and Translational Oncology;2024-07-03

2. Once Upon a Time…. Simple, Sensible Management of Venous Access for Chemotherapy Delivery in Germ Cell Tumors;JCO Oncology Practice;2024-03

3. Thrombembolie-Risikofaktoren und Prophylaxe;Aktuelle Urologie;2023-06-20

4. Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy;Clinical Genitourinary Cancer;2023-02

5. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2022-04